Article Text

Download PDFPDF
Carbonic anhydrase IX: a regulator of pH and participant in carcinogenesis
  1. Alessandro Pietro Aldera1,2,
  2. Dhirendra Govender1,3
  1. 1Division of Anatomical Pathology, University of Cape Town, Cape Town, South Africa
  2. 2JDW Pathology Inc, Cape Town, South Africa
  3. 3Anatomical Pathology, Pathcare Cape Town, Cape Town, South Africa
  1. Correspondence to Dr Alessandro Pietro Aldera, JDW Pathology, 19 Upper Camp Road, Maitland 7405, South Africa; aldera{at}jdwpathology.co.za

Abstract

Carbonic anhydrase IX (CAIX) is a transmembrane metalloenzyme which is upregulated in tumour cells under hypoxic conditions. CAIX expression is induced by the accumulation of hypoxia-inducible factor-1α and has several downstream effects, including acidification of the extracellular pH, loss of cellular adhesion and increased tumour cell migration. CAIX is upregulated in a variety of solid organ tumours and has prognostic implications. High CAIX protein expression is a marker of poor prognosis in breast, lung, ovarian and bladder carcinomas. Conversely, low expression is an indicator of poor prognosis in clear cell renal cell carcinoma (CCRCC). CAIX immunohistochemistry is useful diagnostically to identify metastatic CCRCC, and the recently recognised clear cell papillary renal cell carcinoma. There is much interest in targeting CAIX with monoclonal antibodies and small molecule inhibitors. There are several small molecule inhibitors under development which have shown promising results in clinical trials. In this paper, we provide an overview of the role of CAIX in tumourigenesis and outline its use as a prognostic, diagnostic and therapeutic biomarker.

  • immunohistochemistry
  • kidney neoplasms
  • molecular biology

Statistics from Altmetric.com

Footnotes

  • Handling editor Des Richardson.

  • Contributors Both authors contributed equally.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.